EFSA has published its guidance on how to assess the safety of nanoscience and nanotechnology applications. The guidance gives practical suggestions on the types of testing that are needed and the methods that can be applied.
ViAqua is developing the first orally administered treatment for shrimp that improves resistance to viral diseases, including White Spot Syndrome Virus (WSSV), and prevents viral epidemics.
In a move that would substantially increase ADM’s aquaculture footprint, Archer Daniels Midland Company (ADM) announced that it has agreed to terms granting exclusivity in discussions to purchase Neovia. The 100 percent cash deal has an approximate enterprise value of €1.535 billion, subject to customary adjustments. “Neovia is a major global provider of animal nutrition solutions, with significant operations in Western Europe, South and Central America, and Southeast Asia. Combining Neovia’s global presence and product and innovation expertise with our own growing Animal Nutrition footprint and capabilities would be the ideal platform for future growth.”